Hui Sun1, Xinzhe Ma2, Zhiyong Li1, Jianning Liu1, Wei Wang1, Xiangbei Qi3,4. 1. Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China. 2. Department of Orthopaedic Surgery, Shijiazhuang Third Hospital, Shijiazhuang, China. 3. Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China. qixiangbei126@126.com. 4. Tiemenguan District of the Third Hospital of Hebei Medical University, Tiemenguan City, China. qixiangbei126@126.com.
Abstract
BACKGROUND: This study aimed to prepare the polymethylmethacrylate (PMMA) bone cement release system with different concentrations of enoxaparin sodium (ES) and to investigate the release characteristics of ES after loading into the PMMA bone cement. METHODS: In the experimental group, 40 g Palacos®R PMMA bone cement was loaded with various amount of ES 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, respectively. The control group was not loaded with ES. Scanning electron microscopy (SEM) was used to observe the surface microstructure of the bone cement in the two groups. In the experiment group, the mold was extracted continuously with pH7.4 Tris-HCL buffer for 10 days. The extract solution was collected every day and the anti-FXa potency was measured. The experiment design and statistical analysis were conducted using a quantitative response parallel line method. RESULTS: Under the SEM, it was observed that ES was filled in the pores of PMMA bone cement polymer structure and released from the pores after extraction. There was a burst effect of the release. The release amount of ES on the first day was 0.415, 0.858, 1.110, 1.564, 1.952, and 2.513, respectively, from the six groups with various ES loading amount of 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, all reaching the peak of release on the first day. The release decreased rapidly on the next day and entered the plateau phase on the fourth day. CONCLUSION: The prepared ES-PMMA bone cement has high application potential in orthopedic surgery. ES-PMMA bone cement shows good drug release characteristics. The released enoxaparin sodium has a local anti-coagulant effect within 24 h after application, but it will not be released for a long time, which is complementary to postoperative anti-coagulation therapy.
BACKGROUND: This study aimed to prepare the polymethylmethacrylate (PMMA) bone cement release system with different concentrations of enoxaparin sodium (ES) and to investigate the release characteristics of ES after loading into the PMMA bone cement. METHODS: In the experimental group, 40 g Palacos®R PMMA bone cement was loaded with various amount of ES 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, respectively. The control group was not loaded with ES. Scanning electron microscopy (SEM) was used to observe the surface microstructure of the bone cement in the two groups. In the experiment group, the mold was extracted continuously with pH7.4 Tris-HCL buffer for 10 days. The extract solution was collected every day and the anti-FXa potency was measured. The experiment design and statistical analysis were conducted using a quantitative response parallel line method. RESULTS: Under the SEM, it was observed that ES was filled in the pores of PMMA bone cement polymer structure and released from the pores after extraction. There was a burst effect of the release. The release amount of ES on the first day was 0.415, 0.858, 1.110, 1.564, 1.952, and 2.513, respectively, from the six groups with various ES loading amount of 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, all reaching the peak of release on the first day. The release decreased rapidly on the next day and entered the plateau phase on the fourth day. CONCLUSION: The prepared ES-PMMA bone cement has high application potential in orthopedic surgery. ES-PMMA bone cement shows good drug release characteristics. The released enoxaparin sodium has a local anti-coagulant effect within 24 h after application, but it will not be released for a long time, which is complementary to postoperative anti-coagulation therapy.
Entities:
Keywords:
Bone cement; Enoxaparin sodium; Polymethylmethacrylate; Release characteristics
Authors: Marcus Rohnke; Stefanie Pfitzenreuter; Boris Mogwitz; Anja Henß; Jürgen Thomas; Dina Bieberstein; Thomas Gemming; Svenja K Otto; Seemun Ray; Matthias Schumacher; Michael Gelinsky; Volker Alt Journal: J Control Release Date: 2017-07-27 Impact factor: 9.776
Authors: Daniel L Jones; William A Jones; Kory I Fleming; Thomas F Higgins; David L Rothberg; Yingying Zhang; Christopher J Pannucci Journal: J Orthop Trauma Date: 2019-11 Impact factor: 2.512
Authors: Yue Sa; Na Yu; Joop G C Wolke; Nattharee Chanchareonsook; Bee Tin Goh; Yining Wang; Fang Yang; John A Jansen Journal: Tissue Eng Part C Methods Date: 2017-04-26 Impact factor: 3.056
Authors: Paloma Anguita-Alonso; Mark S Rouse; Kerryl E Piper; David J Jacofsky; Douglas R Osmon; Robin Patel Journal: Clin Orthop Relat Res Date: 2006-04 Impact factor: 4.176